The FDA granted full approval to Leqembi (lecanemab) July 6, six months after handing Eisai and Biogen’s Alzheimer’s drug an accelerated approval.
Read the full post on Becker's Hospital Review - Healthcare News
FDA fully approves Alzheimer's drug Leqembi
